TD Private Client Wealth LLC Lowers Stock Holdings in Danaher Co. (NYSE:DHR)

TD Private Client Wealth LLC lessened its stake in Danaher Co. (NYSE:DHR - Free Report) by 8.3% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 16,458 shares of the conglomerate's stock after selling 1,488 shares during the period. TD Private Client Wealth LLC's holdings in Danaher were worth $3,778,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. Howard Capital Management Group LLC grew its position in shares of Danaher by 4.1% during the 3rd quarter. Howard Capital Management Group LLC now owns 1,229 shares of the conglomerate's stock worth $342,000 after buying an additional 48 shares in the last quarter. Citizens Financial Group Inc. RI lifted its stake in Danaher by 17.3% in the third quarter. Citizens Financial Group Inc. RI now owns 16,940 shares of the conglomerate's stock worth $4,713,000 after acquiring an additional 2,499 shares during the period. LPL Financial LLC grew its holdings in Danaher by 7.4% during the 3rd quarter. LPL Financial LLC now owns 379,341 shares of the conglomerate's stock worth $105,464,000 after acquiring an additional 26,124 shares in the last quarter. Pacer Advisors Inc. increased its position in Danaher by 0.4% during the 3rd quarter. Pacer Advisors Inc. now owns 51,110 shares of the conglomerate's stock valued at $14,210,000 after purchasing an additional 220 shares during the period. Finally, Lathrop Investment Management Corp raised its holdings in shares of Danaher by 13.8% in the 3rd quarter. Lathrop Investment Management Corp now owns 25,705 shares of the conglomerate's stock valued at $7,147,000 after purchasing an additional 3,125 shares in the last quarter. Institutional investors own 79.05% of the company's stock.

Remove Ads

Insider Buying and Selling at Danaher

In related news, SVP Brian W. Ellis sold 5,700 shares of the business's stock in a transaction on Thursday, January 30th. The shares were sold at an average price of $224.13, for a total value of $1,277,541.00. Following the completion of the transaction, the senior vice president now directly owns 20,230 shares in the company, valued at $4,534,149.90. The trade was a 21.98 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. 11.10% of the stock is currently owned by corporate insiders.

Danaher Stock Performance

Shares of NYSE:DHR traded down $2.25 during midday trading on Wednesday, reaching $210.15. The company's stock had a trading volume of 2,669,221 shares, compared to its average volume of 3,011,853. The company has a quick ratio of 1.05, a current ratio of 1.40 and a debt-to-equity ratio of 0.31. The stock has a fifty day moving average of $216.41 and a 200 day moving average of $237.75. Danaher Co. has a twelve month low of $196.80 and a twelve month high of $281.70. The firm has a market capitalization of $150.19 billion, a PE ratio of 39.80, a P/E/G ratio of 2.66 and a beta of 0.82.

Danaher (NYSE:DHR - Get Free Report) last announced its quarterly earnings results on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share for the quarter, hitting the consensus estimate of $2.14. Danaher had a return on equity of 10.82% and a net margin of 16.33%. During the same quarter in the prior year, the company posted $2.09 EPS. On average, equities analysts expect that Danaher Co. will post 7.63 EPS for the current fiscal year.

Danaher Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, April 25th. Investors of record on Friday, March 28th will be given a dividend of $0.32 per share. This is a boost from Danaher's previous quarterly dividend of $0.27. This represents a $1.28 annualized dividend and a yield of 0.61%. The ex-dividend date is Friday, March 28th. Danaher's dividend payout ratio (DPR) is currently 24.24%.

Analysts Set New Price Targets

DHR has been the subject of a number of analyst reports. StockNews.com cut Danaher from a "buy" rating to a "hold" rating in a research note on Saturday, December 14th. Barclays lowered their price target on shares of Danaher from $275.00 to $240.00 and set an "equal weight" rating on the stock in a report on Thursday, January 30th. Robert W. Baird reduced their price objective on shares of Danaher from $277.00 to $268.00 and set an "overweight" rating for the company in a research note on Tuesday, January 28th. Wells Fargo & Company lowered their target price on shares of Danaher from $280.00 to $240.00 and set an "equal weight" rating for the company in a research note on Thursday, January 30th. Finally, Royal Bank of Canada reaffirmed an "outperform" rating and set a $277.00 price target (down from $299.00) on shares of Danaher in a research report on Thursday, January 30th. Five analysts have rated the stock with a hold rating and seventeen have given a buy rating to the company's stock. Based on data from MarketBeat.com, Danaher has a consensus rating of "Moderate Buy" and an average target price of $278.24.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.